XML 44 R19.htm IDEA: XBRL DOCUMENT v3.24.1
Collaborative Agreements
12 Months Ended
Dec. 31, 2023
Collaborative Agreements [Abstract]  
COLLABORATIVE AGREEMENTS

NOTE 11 – COLLABORATIVE AGREEMENTS

 

During September 2020, the Company was awarded a grant of up to $2.9 million from the National Institutes of Health (“NIH”). The grant will support a Phase 2 study of XPro in patients with treatment resistant depression. As of December 31, 2023, the Company has not received any proceeds pursuant to this grant.